These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20634801)

  • 1. 8q24 allelic imbalance and MYC gene copy number in primary prostate cancer.
    Chen H; Liu W; Roberts W; Hooker S; Fedor H; DeMarzo A; Isaacs W; Kittles RA
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):238-43. PubMed ID: 20634801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma.
    Sato K; Qian J; Slezak JM; Lieber MM; Bostwick DG; Bergstralh EJ; Jenkins RB
    J Natl Cancer Inst; 1999 Sep; 91(18):1574-80. PubMed ID: 10491435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
    Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB
    Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
    Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
    Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.
    Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR
    Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
    Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
    Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma].
    Zeng X; Wu SF; Xu Q; Xiao Y; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):523-8. PubMed ID: 17134545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic imbalance at an 8q24 oncogenic SNP is involved in activating MYC in human colorectal cancer.
    Sugimachi K; Niida A; Yamamoto K; Shimamura T; Imoto S; Iinuma H; Shinden Y; Eguchi H; Sudo T; Watanabe M; Tanaka J; Kudo S; Hase K; Kusunoki M; Yamada K; Shimada Y; Sugihara K; Maehara Y; Miyano S; Mori M; Mimori K
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S515-21. PubMed ID: 24390711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
    Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical margin and Gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance.
    Zhou W; Goodman M; Lyles RH; Lim SD; Williams TY; Rusthoven KE; Mandel JS; Amin MB; Petros JA
    Prostate; 2004 Sep; 61(1):81-91. PubMed ID: 15287096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.
    Troutman SM; Sissung TM; Cropp CD; Venzon DJ; Spencer SD; Adesunloye BA; Huang X; Karzai FH; Price DK; Figg WD
    Oncologist; 2012; 17(3):312-20. PubMed ID: 22382457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.
    Penney KL; Salinas CA; Pomerantz M; Schumacher FR; Beckwith CA; Lee GS; Oh WK; Sartor O; Ostrander EA; Kurth T; Ma J; Mucci L; Stanford JL; Kantoff PW; Hunter DJ; Stampfer MJ; Freedman ML
    Clin Cancer Res; 2009 May; 15(9):3223-30. PubMed ID: 19366828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1.
    Dvorácková J; Uvírová M
    Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
    Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
    PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer.
    Zhao J; Wu XY; Ling XH; Lin ZY; Fu X; Deng YH; He HC; Zhong W
    Med Oncol; 2013 Mar; 30(1):465. PubMed ID: 23377984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.